Celestial Biolabs Ltd vs CIPLA LTD

A side-by-side comparison of Celestial Biolabs Ltd (CELESTIAL) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, CIPLA LTD leads CELESTIAL vs CIPLA on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
29.42
0.00
P/B ratio
3.42
0.00%
Dividend yield
0.92%
₹-0.26
EPS
₹48.02

Profitability

CIPLA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-18.90%
Return on equity
11.60%
-3.84%
Return on capital
15.00%
-317.65%
EBITDA margin
21.00%
-341.18%
Net margin
13.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
7.37%
Profit CAGR (3Y) even
10.88%

Size & financial health

CIPLA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.14L Cr
₹0 Cr
Revenue
₹28,163 Cr
₹-1 Cr
Net profit
₹3,862 Cr
0.00
Debt / equity
0.00
Celestial Biolabs Ltd
  • ["Company has low interest coverage ratio.", "Contingent liabilities of Rs.1.29 Cr.", "Company might be capitalizing the interest cost", "Company has high debtors of 7,966 days."]
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
Celestial Biolabs Ltd full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.